Atrial Fibrillation

Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure

Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure

By

Catheter ablation is superior to drug therapy in improving all-cause mortality, LVEF, 6-minute walk test distance, VO2max, and quality of life in patients with heart failure.

Should CHA2DS2-VASc Be Reassessed More Frequently to Improve Stroke Prevention in Afib?

Should CHA2DS2-VASc Be Reassessed More Frequently to Improve Stroke Prevention in Afib?

By

These results suggest that CHA2DS2-VASc scores should be continually reassessed, perhaps annually, in patients with atrial fibrillation.

Study Reveals High Rate of Phlebitis Caused by IV Cannulas

Study Reveals High Rate of Phlebitis Caused by IV Cannulas

The incidence of phlebitis caused by peripheral intravenous cannula insertions may be higher among patients with certain risk factors.

FDA Approval Expands Access to Factor Xa Inhibitor Antidote Andexxa

FDA Approval Expands Access to Factor Xa Inhibitor Antidote Andexxa

By

Andexxa was initially granted accelerated approval in May 2018 for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation was needed due to life-threatening or uncontrolled bleeding.

Sodium Intake Associated With Long-Term New Onset Afib Risk

Sodium Intake Associated With Long-Term New Onset Afib Risk

Sodium intake is associated with the long-term risk of new-onset atrial fibrillation.

Catheter Ablation May Be Superior to Drug Therapy in Heart Failure With Afib

Catheter Ablation May Be Superior to Drug Therapy in Heart Failure With Afib

Catheter ablation is better than drug therapy for the treatment of atrial fibrillation in patients with heart failure.

Atrial Fibrillation Risk Increased With Antidepressant Use

Atrial Fibrillation Risk Increased With Antidepressant Use

The risk for atrial fibrillation is increased among antidepressant users, particularly before treatment initiation.

Hospitalization for Upper GI Bleed Highest With Rivaroxaban

Hospitalization for Upper GI Bleed Highest With Rivaroxaban

For patients initiating oral anticoagulant therapy, the incidence of hospitalization for upper gastrointestinal bleeding is highest and lowest with rivaroxaban and apixaban, respectively.

Racial Disparities Seen in Use of Oral Anticoagulants for Afib

Racial Disparities Seen in Use of Oral Anticoagulants for Afib

Black patients with atrial fibrillation are less likely to receive DOACs compared with white patients, even after controlling for clinical and sociodemographic features.

Occupational Exposure to Metals, Pesticides Tied to CVD in Hispanics

Occupational Exposure to Metals, Pesticides Tied to CVD in Hispanics

Occupational exposures to pesticides and metals are associated with an increased prevalence of CVD among Hispanics/Latinos.

Botox Injections Explored to Reduce Postop AF in Cardiac Surgery

Botox Injections Explored to Reduce Postop AF in Cardiac Surgery

Intraoperative botulinum toxin injections show promise as a way to reduce the risk for postoperative atrial fibrillation following cardiac surgery.

Migraine With Aura Linked to Increase in Incident Atrial Fibrillation

Migraine With Aura Linked to Increase in Incident Atrial Fibrillation

Migraine with aura is associated with an elevated risk for incident atrial fibrillation.

High Free T4 Levels Within Reference Range Associated With Atrial Fibrillation

High Free T4 Levels Within Reference Range Associated With Atrial Fibrillation

By

Higher levels of free T4 that remain within the reference range are associated with a greater prevalence and incidence of atrial fibrillation.

ARISTOTLE: Combining NSAIDs With Oral Anticoagulants Increases Bleeding Risk in AF

ARISTOTLE: Combining NSAIDs With Oral Anticoagulants Increases Bleeding Risk in AF

By

While the use of NSAIDs was low in the ARISTOTLE trial, NSAID users had a higher risk for bleeding than non-users.

Vitamin D Plus Calcium Supplementation May Not Modify Atrial Fibrillation Risk

Vitamin D Plus Calcium Supplementation May Not Modify Atrial Fibrillation Risk

By

Baseline serum 25(OH)D level was not predictive of long-term incident atrial fibrillation risk.

DOAC Safety, Efficacy Similar to Warfarin for Nonvalvular Atrial Fibrillation

DOAC Safety, Efficacy Similar to Warfarin for Nonvalvular Atrial Fibrillation

By

The currently available DOACS are at least as effective and safe as warfarin for patients with nonvalvular atrial fibrillation.

Opioid Use Linked to Increased Atrial Fibrillation Risk

Opioid Use Linked to Increased Atrial Fibrillation Risk

Opioid use is associated with the risk for developing atrial fibrillation.

Cardiologist Involvement Associated With Favorable Afib Outcomes in Patients With Cancer

Cardiologist Involvement Associated With Favorable Afib Outcomes in Patients With Cancer

Atrial fibrillation patients with cancer are less likely to see a cardiologist and fill prescriptions for anticoagulants.

Smartwatch Algorithm Highly Effective for Detection of Atrial Fibrillation

Smartwatch Algorithm Highly Effective for Detection of Atrial Fibrillation

By

The KardiaBand allows patients to collect an electrocardiogram (ECG) reading using their Apple Watch.

Thromboembolism Risk Linked to New-Onset Atrial Fibrillation After Noncardiac Surgery

Thromboembolism Risk Linked to New-Onset Atrial Fibrillation After Noncardiac Surgery

By

New-onset atrial fibrillation developed after noncardiac surgery is associated with a long-term risk of thromboembolism.

Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women

Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women

By

There may be a relationship between traumatic life event stress and atrial fibrillation in women over the age of 45 years old.

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

By

Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.

Atrial Fibrillation Tied to Higher Dementia Risk in Older Adults

Atrial Fibrillation Tied to Higher Dementia Risk in Older Adults

Atrial fibrillation is associated with a faster global cognitive decline and an increased risk for dementia in older people, though anticoagulants may reduce dementia risk in AF patients.

Genetic Predisposition to Early-Onset AF Noted Across Racial and Ethnic Groups

Genetic Predisposition to Early-Onset AF Noted Across Racial and Ethnic Groups

Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation are more likely than European Americans to have a first-degree relative with AF

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

By

Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.

Net Clinical Benefits of Anticoagulants for AF Vary With Stroke Rate

Net Clinical Benefits of Anticoagulants for AF Vary With Stroke Rate

There is variation in the net clinical benefit of anticoagulants based on variation in published atrial fibrillation stroke rates.

Effect of Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

Effect of Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

For high-risk patients with implantable cardioverter-defibrillators, ranolazine does not significantly reduce the risk of ventricular tachycardia, or ventricular fibrillation.

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

By

The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

By

The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

By

Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.

Sign Up for Free e-Newsletters